These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36771595)
1. Investigation of Patil N; Chandel V; Rana A; Jain M; Kaushik P Plants (Basel); 2023 Jan; 12(3):. PubMed ID: 36771595 [No Abstract] [Full Text] [Related]
2. Molecular docking and molecular dynamics approach to identify potential compounds in Tung BT; Hang TTT; Kim NB; Nhung NH; Linh VK; Thu DK J Complement Integr Med; 2022 Dec; 19(4):955-965. PubMed ID: 35621378 [TBL] [Abstract][Full Text] [Related]
3. A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations. Azmal M; Hossen MS; Shohan MNH; Taqui R; Malik A; Ghosh A PLoS One; 2024; 19(6):e0304490. PubMed ID: 38833492 [TBL] [Abstract][Full Text] [Related]
4. Lepidine B from Lepidium sativum Seeds as Multi-Functional Anti- Alzheimer's Disease Agent: In Vitro and In Silico Studies. Talia S; Benarous K; Lamrani M; Yousfi M Curr Comput Aided Drug Des; 2021; 17(3):360-377. PubMed ID: 32116197 [TBL] [Abstract][Full Text] [Related]
5. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches. Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968 [TBL] [Abstract][Full Text] [Related]
6. Insights of Valacyclovir in Treatment of Alzheimer's Disease: Computational Docking Studies and Scopolamine Rat Model. Patel P; Faldu K; Borisa A; Bhatt H; Shah J Curr Neurovasc Res; 2022; 19(3):344-357. PubMed ID: 36089794 [TBL] [Abstract][Full Text] [Related]
7. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study. Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419 [TBL] [Abstract][Full Text] [Related]
8. In vitro cholinesterase inhibitory action of Karimi I; Yousofvand N; Hussein BA In Silico Pharmacol; 2021; 9(1):13. PubMed ID: 33520592 [TBL] [Abstract][Full Text] [Related]
9. Cannabis Sativa L. Flower and Bud Extracts Inhibited In vitro Cholinesterases and β-Secretase Enzymes Activities: Possible Mechanisms of Cannabis Use in Alzheimer Disease. Mooko T; Bala A; Tripathy S; Kumar CS; Mahadevappa CP; Chaudhary SK; Matsabisa MG Endocr Metab Immune Disord Drug Targets; 2022; 22(3):297-309. PubMed ID: 33618651 [TBL] [Abstract][Full Text] [Related]
10. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment. Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169 [TBL] [Abstract][Full Text] [Related]
11. Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment. Farihi A; Bouhrim M; Chigr F; Elbouzidi A; Bencheikh N; Zrouri H; Nasr FA; Parvez MK; Alahdab A; Ahami AOT Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893530 [No Abstract] [Full Text] [Related]
12. Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer's Disease. Londhe SG; Walhekar V; Shenoy M; Kini SG; Scotti MT; Scotti L; Kumar D Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204336 [TBL] [Abstract][Full Text] [Related]
13. In Silico Design of Dual-Binding Site Anti-Cholinesterase Phytochemical Heterodimers as Treatment Options for Alzheimer's Disease. Amat-Ur-Rasool H; Ahmed M; Hasnain S; Ahmed A; Carter WG Curr Issues Mol Biol; 2021 Dec; 44(1):152-175. PubMed ID: 35723391 [TBL] [Abstract][Full Text] [Related]
14. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment. Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176 [TBL] [Abstract][Full Text] [Related]